‰ك‹ژƒچƒO

پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@‚o‚پ‚‡‚…     797
„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ
پ@پ@پ@’تڈيƒ‚پ[ƒh‚ة–ك‚éپ@پ@„«پ@پ@‚h‚m‚c‚d‚wپ@پ@„«پ@پ@پل‘O‚ضپ@پ@„ پ@پ@ژں‚ضپâپ@پ@پ@
„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ
پ@پ¥Pharming Announces  oblipserpourb 08/7/27(“ْ) 12:26

پ@„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں„ں
پ@پ،‘è–¼ پF Pharming Announces
پ@پ،–¼‘O پF oblipserpourb <werseteur@gmail.com>
پ@پ،“ْ•t پF 08/7/27(“ْ) 12:26
پ@پ،‚v‚…‚‚ پF http://yahoo.com
پ@-------------------------------------------------------------------------
    LEIDEN, The Netherlands, July 11, 2008- Biotech associates Pharming band NV (“Pharming” or “the companionship”) (NYSE Euronext: PHARM) announced today unquestioned results from non-stop expand-characterize studies with recombinant kindly C1 inhibitor (Rhucin®) for the treatment of wise attacks of inherited Angioedema (AE). 

 

The unquestioned results are from the treatment of 123 wise HAE attackks in 64 patients with distinct doses of Rhucin® in the unfolding European and North American expand-hallmark studies. Rhucin® has been staunchly sure and conspicuyous in patients receiving up to nine treatments with no basis of decreased reply to the over drug. Importantly, all seven acheter cialis laryngeal attacks treated in these studies responded instanter to Rhucin®. The make known-name details are in keeping with findings from Pharming’s two randomized, copy-shutters, placebo-lead led studies of Rhucin® with a median nonetheless to hit of achat cialis of one hour and a median often to slightest symptoms of four hours. 

 

Dr. Bruno Giannetti, Chief Opertations public official at Pharming, commented: “We are greatly walking on air with these unquestioned results with Rhucin®. They pharming announces the clinical benefits of Rhucin®, also in duplicate treatment, without showing any adverse reactions or insusceptible answers. Furthermore, the amount individual of treatments has actually multiplyd 

, including the loaded treatment of impressive potentially memiors-foreboding laryngeal attacks. We exceptionally much acheter cialis the fortifying of the investigators and patients with HAE with these clinical trials. These studies are an outstanding contribution to making Rhucin® close by for HAE patients worldwide.” 

 

The results from make known-characterize studies authenticate Rhucin® to be sure and conspicuous in the rerun treatment of wise HAE attacks at divers dosage regimens. No clinically significant adverse reactions were replorted from these studies. The make known-name treatments assert a sub stantial diunpunctual to the Rhucin® clinical informationbaase and resolution be inured to to subsidize planned regulatory usbmissions. acheter cialis Rhucin® and HAE Rhucin® (recombinant compassionate C1 esterase inhibitor) is a compassionzte protein developed result ot Pharming’s proprietary technology whered the compassionate protein is expressed in draw off of transgenic rabbits. Rhucin® is currently junior to maturity for treatment of patients with wise attacks of handed down Angioedema (HAE). HAE is a kindly genetic pharming announces caemployed by a achat cialisl of C1 inhibitor vocation and resulst in an overreaction of the protected sysetm. The affliction is characterized by discerning attacks of nociceptive and in some cases fateful protrusion of a varieyt of pendic tissues (edema), which may end up to five days when untreated. around Pharming band NVPharming band NV is developing 

innovative products for the treatment of genetic complaints, ageing afflictions, specialtyu producdts for surgical indications, intermediates for a variety of applications and nutriitonal products. Pharing has two products in unpunctual rostrum show business expansion - Rhucin® for inherited Anhioedema and compassionate lactoferrin for use in rations products. The advanced technologies of the public limitedپ@incorporate innovative platforms for the manufacture of protein therapeutics, technology and processes for the purification and formulation of these products, as reaswonably as technology in the achat cialis of DNA state (via DNage).

„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ
پ@پ@پ@’تڈيƒ‚پ[ƒh‚ة–ك‚éپ@پ@„«پ@پ@‚h‚m‚c‚d‚wپ@پ@„«پ@پ@پل‘O‚ضپ@پ@„ پ@پ@ژں‚ضپâپ@پ@پ@
„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ„ھ
پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@پ@‚o‚پ‚‡‚…     797